DE3472114D1 - Plasmids and modified strains of vibrio cholerae, their preparation and derived vaccines - Google Patents

Plasmids and modified strains of vibrio cholerae, their preparation and derived vaccines

Info

Publication number
DE3472114D1
DE3472114D1 DE8484870058T DE3472114T DE3472114D1 DE 3472114 D1 DE3472114 D1 DE 3472114D1 DE 8484870058 T DE8484870058 T DE 8484870058T DE 3472114 T DE3472114 T DE 3472114T DE 3472114 D1 DE3472114 D1 DE 3472114D1
Authority
DE
Germany
Prior art keywords
vibrio cholerae
plasmids
modified strains
preparation
derived vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484870058T
Other languages
English (en)
Inventor
John J Mekalanos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of DE3472114D1 publication Critical patent/DE3472114D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/909—Vibrio

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DE8484870058T 1983-04-29 1984-04-26 Plasmids and modified strains of vibrio cholerae, their preparation and derived vaccines Expired DE3472114D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/489,958 US4882278A (en) 1983-04-29 1983-04-29 Non-toxinogenic vibrio cholerae mutants

Publications (1)

Publication Number Publication Date
DE3472114D1 true DE3472114D1 (en) 1988-07-21

Family

ID=23945983

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484870058T Expired DE3472114D1 (en) 1983-04-29 1984-04-26 Plasmids and modified strains of vibrio cholerae, their preparation and derived vaccines

Country Status (20)

Country Link
US (1) US4882278A (de)
EP (1) EP0125228B1 (de)
JP (1) JPH0740921B2 (de)
AT (1) ATE35152T1 (de)
AU (1) AU585481B2 (de)
CA (1) CA1326218C (de)
DE (1) DE3472114D1 (de)
DK (1) DK213784A (de)
DZ (1) DZ634A1 (de)
EG (1) EG17879A (de)
ES (1) ES8600649A1 (de)
GR (1) GR81986B (de)
IE (1) IE57266B1 (de)
IL (1) IL71652A (de)
PH (1) PH25301A (de)
PT (1) PT78478B (de)
YU (1) YU45616B (de)
ZA (1) ZA843142B (de)
ZM (1) ZM2884A1 (de)
ZW (1) ZW6884A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470729A (en) * 1983-03-04 1995-11-28 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US5399494A (en) * 1983-03-04 1995-03-21 The University Of Maryland System Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof
US5882653A (en) * 1983-03-04 1999-03-16 The University Of Maryland System Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
EP0249449A1 (de) * 1986-06-11 1987-12-16 Enterovax Research Pty. Ltd. Bakterieller Stamm für lebende Impfstoffe
SE462285B (sv) * 1988-09-16 1990-05-28 Jan Roland Holmgren Expression av koleratoxinets bindande subenhet med hjaelp av fraemmande promotor- och/eller ledarpeptidstrukturer
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
ES2095322T3 (es) * 1990-06-05 1997-02-16 Univ Maryland Procedimiento para aislar mutantes de delecion vibrio cholerae y cultivos que contienen vibrio cholerae.
IL101715A (en) * 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
DE69333028T2 (de) * 1992-07-06 2004-04-22 The President And Fellows Of Harvard College, Cambridge Deletionsmutanten als impfstoffe gegen cholera
US5874088A (en) * 1992-07-06 1999-02-23 President And Fellows Of Harvard College Deletion mutants of cholera vaccines expressing heterologous antigens
WO1994019482A1 (en) * 1993-02-22 1994-09-01 The General Hospital Corporation Heterologous antigens in live cell vaccine strains
US6203799B1 (en) 1993-07-01 2001-03-20 Presidents And Fellows Of Harvard College Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit
WO1997049289A1 (en) * 1996-06-27 1997-12-31 President And Fellows Of Harvard College Vibrio cholerae having increased sensitivity to antibiotics
AU7410798A (en) * 1996-11-29 1998-06-22 General Hospital Corporation, The Heterologous antigens in live cell V
JP4086945B2 (ja) * 1996-12-10 2008-05-14 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ 非毒性Ｖ．Ｃｈｏｌｅｒａｅ株の単離法およびその株由来のコレラワクチンの製造法
EP0928831B1 (de) * 1997-12-10 2006-05-03 Council of Scientific and Industrial Research Choleraorganismen, Impfstoffe und ihre Verwendung
US6541011B2 (en) 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
US7390619B1 (en) 1998-02-11 2008-06-24 Maxygen, Inc. Optimization of immunomodulatory properties of genetic vaccines
EP1056842A2 (de) * 1998-02-11 2000-12-06 Maxygen, Inc. Genetische impfstoff vektor herstellung
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
EP1105490A1 (de) 1998-08-20 2001-06-13 Aventis Pasteur Limited Einschlussmembranprotein c von chlamydia kodierende nukleinsäuremoleküle
US6686339B1 (en) * 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
ATE391726T1 (de) 1999-10-22 2008-04-15 Sanofi Pasteur Ltd Modifiziertes gp100 und dessen verwendung
EP1792995A3 (de) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
WO2001085932A2 (en) 2000-05-10 2001-11-15 Aventis Pasteur Limited Immunogenic polypeptides encoded by mage minigenes and uses thereof
EP1343894A4 (de) * 2000-11-02 2005-05-04 Univ Singapore Aopb-gen, -protein, homologe, fragmente und varianten davon und ihre verwendung bei der zelloberflächenpräsentation
WO2003085087A2 (en) 2002-04-09 2003-10-16 Aventis Pasteur, Limited Modified cea nucleic acid and expression vectors
US20060251667A1 (en) * 2002-08-29 2006-11-09 Chua Kaw Y Recombinant nucleic acid useful for inducing protective immune response against allergens
JP4668919B2 (ja) * 2003-10-08 2011-04-13 サノフィ パストゥール インコーポレイテッド 修飾ｃｅａ／ｂ７ベクター
US20060099229A1 (en) * 2004-11-05 2006-05-11 Universiti Sains Malaysia Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264737A (en) * 1978-09-21 1981-04-28 President And Fellows Of Harvard College Method of making genetically stable mutants of vibrio cholerae
US4328209A (en) * 1979-04-11 1982-05-04 Board Of Regents, The University Of Texas System Cholera vaccine
JPS5893837A (ja) * 1981-11-30 1983-06-03 Toyota Motor Corp 複合材料及びその製造方法
US4666837A (en) * 1982-05-24 1987-05-19 Smithkline-Rit DNA sequences, recombinant DNA molecules and processes for producing the A and B subunits of cholera toxin and preparations containing so-obtained subunit or subunits
ZA841557B (en) * 1983-03-04 1984-10-31 Univ Maryland Method of isolating restriction fragment deletions in vibrio chlolerae,and products thereof
US5135862A (en) * 1983-03-04 1992-08-04 University Of Maryland Method of isolating restriction fragment deletions in vibrio cholerae, products thereof

Also Published As

Publication number Publication date
CA1326218C (en) 1994-01-18
GR81986B (de) 1984-12-12
ATE35152T1 (de) 1988-07-15
PH25301A (en) 1991-04-30
ES531986A0 (es) 1985-09-01
YU45616B (sh) 1992-07-20
EG17879A (en) 1991-08-30
DZ634A1 (fr) 2004-09-13
IL71652A (en) 1988-11-30
EP0125228B1 (de) 1988-06-15
YU76384A (en) 1989-08-31
PT78478B (en) 1986-05-27
JPH0740921B2 (ja) 1995-05-10
EP0125228A1 (de) 1984-11-14
ZW6884A1 (en) 1984-09-19
DK213784D0 (da) 1984-04-27
IE57266B1 (en) 1992-07-01
DK213784A (da) 1984-10-30
AU585481B2 (en) 1989-06-22
IE841043L (en) 1984-10-29
US4882278A (en) 1989-11-21
ES8600649A1 (es) 1985-09-01
IL71652A0 (en) 1984-07-31
AU2727084A (en) 1984-11-01
ZA843142B (en) 1985-03-27
JPS6037980A (ja) 1985-02-27
ZM2884A1 (en) 1985-04-22
PT78478A (en) 1984-05-01

Similar Documents

Publication Publication Date Title
DE3472114D1 (en) Plasmids and modified strains of vibrio cholerae, their preparation and derived vaccines
ES8605039A1 (es) Procedimiento para preparar una vacuna que comprende un derivado truncado, libre de una membrana de un tipo fijado a una membrana que tiene determinantes antigenicos expuestos.
AU2785089A (en) Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
GR3004448T3 (de)
DK219087A (da) Vektorsystem til brug ved transformation af trichoderma, transformerede trichodermastammer og fremgangsmaade til fremstilling af proteiner heri
DE3266201D1 (en) Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines and infectious-bronchitis virus strain
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
FI851859A0 (fi) Antigenpreparat och isolering av saodana preparat.
DK314485D0 (da) Derivat af humant interferon-gamma-polypeptid, recombinant plasmid til brug ved fremstilling deraf, fremgangsmaade til fremstilling deraf og mikroorganisme indeholdende recombinant plasmid
ZA874625B (en) Stabilizers for live vaccines,process for their preparation and vaccines containing them
BG41136A3 (en) Method for preparing dna transfering vector intended for maintenance and replication of desoxynucleotide sequence coding human proinsuline
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
FI102544B1 (fi) Menetelmä E.coli-kannan valmistamiseksi
HUT44609A (en) Process for preparing new polypeptides
SE8205247L (sv) Fiskvacciner
JO1343B1 (en) Non-toxic gene variant strains of vibro cholera
IL85759A0 (en) The cloning of malaria-specific dna sequences,isolation of the gene for the 140 kd protein
AU7384387A (en) Avirulent bacterial strains used in live vaccine preparation
AR224831A1 (es) Un procedimiento para la elaboracion de preparados de paredes celulares o preparaciones de celulas completas de propionibacterium granulosum dsm 1773,propionibacterium avidum dms 1772 y/o propionibacterium acnes atcc 6919
AU2713488A (en) Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process
EP0290246A3 (de) Impfstoff zur Erzeugung einer gegen Tollwutvirus schützenden immunogenen T-Zellen-Respons
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ

Legal Events

Date Code Title Description
8364 No opposition during term of opposition